Indo US Bio-Tech Ltd Q1 FY2026-2027 Results: Summary
Revenue | ₹33.11Cr |
Net Profits | ₹3.04Cr |
Net Profit Margins | 9.18% |
Indo US Bio-Tech Ltd’s revenue jumped 7.6% since last year same period to ₹33.11Cr in the Q1 2026-2027. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 27.1% jump in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit fell -35.32% since last year same period to ₹3.04Cr in the Q1 2026-2027. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 54.31% jump in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin fell -39.89% since last year same period to 9.18% in the Q1 2026-2027. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 21.41% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Indo US Bio-Tech Ltd in Q1 results 2026?
The revenue for Indo US Bio-Tech Ltd in the Q1 results 2026 was ₹33.11Cr.
What was the net profit for Indo US Bio-Tech Ltd in Q1 results 2026?
The net profit for Indo US Bio-Tech Ltd in the Q1 results 2026 was ₹3.04Cr.
What was the net profit margin for Indo US Bio-Tech Ltd in Q1 results 2026?
The net profit margin for Indo US Bio-Tech Ltd in the Q1 results 2026 was 9.18%.
What was the revenue for Indo US Bio-Tech Ltd in Q1 results 2025?
The revenue for Indo US Bio-Tech Ltd in the Q1 results 2025 was ₹30.77Cr.
What was the net profit for Indo US Bio-Tech Ltd in Q1 results 2025?
The net profit for Indo US Bio-Tech Ltd in the Q1 results 2025 was ₹4.70Cr.
What was the net profit margin for Indo US Bio-Tech Ltd in Q1 results 2025?
The net profit margin for Indo US Bio-Tech Ltd in the Q1 results 2025 was 15.27%.
